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Abstract
Background: Many studies have investigated the association between vitamin D and metabolic syndrome (MetS).
However, few studies have investigated the association stratified by sex in the elderly. Therefore, we aimed to
evaluate the association between vitamin D, MetS, and its components in Korean elderly men and women.
Methods: A total of 987 men and 1949 women aged ≥65 years were recruited through Korean Urban Rural Elderly
cohort study. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized into 4 quartiles and all data were
analyzed separately by sex. MetS was defined by the revised criteria of the National Cholesterol Education Program
Adult Treatment Panel III.
Results: The participants in the lowest quartile of serum 25(OH)D showed a significant increase in the prevalence
of high waist circumference, elevated triglyceride level, and low high-density lipoprotein cholesterol level, as well as
MetS itself, in both men and women in a univariate analysis. After adjusting for potential confounders including
age, smoking status, drinking status, exercise status, region of residence, seasonality, and parathyroid hormone level,
the lowest 25(OH)D quartile group was associated with a higher risk of MetS (odds ratio [OR] 2.25, 95% confidence
interval [CI] 1.48–3.43 in men and OR 1.65, 95% CI 1.27–2.16 in women) compared to the highest 25(OH)D quartile
group as the reference group. However, no significant association was found between serum 25(OH)D levels and
the prevalence of MetS components including hyperglycemia or hypertension in both men and women.
Conclusions: Low 25(OH)D levels were associated with increased odds of MetS; in particular, they were associated
with MetS components of high waist circumference, hypertriglyceridemia, and low high-density lipoprotein-
cholesterol, after adjusting for age, smoking, alcohol, exercise, region of residency, and seasonality, in men and
women over 65 years old.
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Background
Vitamin D deficiency is a frequent public health issue
in the elderly worldwide. In Korea, vitamin D defi-
ciency was found in 47.3% of men and 64.5% females
in 2008 [1]. More than 50% of women and 30% men
had vitamin D levels below 20 ng/mL among individ-
uals in their 60s and older populations in 2008 [1].
Vitamin D plays an important role in various physio-
logical functions including maintaining calcium
homeostasis and bone health. As vitamin D receptors
are distributed in most of tissues like the muscle,
pancreas, brain, prostate, and breast, among others,
vitamin D is also involved in various extra-skeletal
functions [2–4]. In the elderly, vitamin D deficiency is
not only considered the risk factor of osteoporosis
and fractures but also is associated with beta cell dys-
function and increased insulin resistance leading to
cardiometabolic diseases such as diabetes and meta-
bolic syndrome (MetS) [3–6].
MetS is a cluster of factors that have insulin resistant
characteristics such as high waist circumference, high
blood pressure, high blood sugar, and hyperlipidemia.
MetS is one of the major public health concerns with in-
creasing prevalence. The prevalence of MetS was 31.3%
in 2007 in Korea. Notably, the prevalence of MetS was
the highest in individuals in their 60s with as high as >
70% in women and approximately 50% in men [7]. Be-
cause vitamin D deficiency causes insulin resistance
which is linked to MetS, the associations between vita-
min D deficiency and MetS have been studied [8–10].
Many studies have revealed that vitamin D deficiency in-
creases the prevalence of MetS in various populations.
However, the results about the associations between the
vitamin D level and each component of MetS in differ-
ent populations are inconsistent [9, 11]. Moreover, there
were few studies focusing on the association of vitamin
D level and MetS by sex-stratification over 65 years old.
Thus, we aimed to elucidate the association of MetS and
its components on the basis of vitamin D levels in eld-
erly Korean men and women, separately.
Methods
Study population and data collection
We studied 2936 participants including 987 men and
1949 women aged ≥65 years from the Korean Urban
Rural Elderly cohort study [12]. Serum 25-
hydroxyvitamin D (25(OH)D) levels were categorized
into 4 quartiles for both men and women. The revised
criteria of the National Cholesterol Education Program
Adult Treatment Panel III (NCEP-ATP III) were used to
define MetS [13, 14]. MetS was diagnosed if ≥3 of the
following criteria were met: (i) high waist circumference,
defined as a waist circumference ≥ 90 cm for men or ≥
80 cm for women; (ii) hypertriglyceridemia, defined as
serum triglyceride level ≥ 150 mg/dL; (iii) low high-
density lipoprotein (HDL) cholesterol, defined as a
serum HDL cholesterol level < 40mg/dL for men or < 50
mg/dL for women; (iv) hypertension, defined as a sys-
tolic blood pressure ≥ 130 mmHg, diastolic blood pres-
sure ≥ 85 mmHg, or the use of an antihypertensive drug;
(v) hyperglycemia, defined as fasting glucose ≥100mg/
dL or the use of an antidiabetic drug. The study protocol
was approved by the Ethics Committee of Severance
Hospital (Seoul, Korea) (IRB No. 4–2012-0172).
Biochemical measurements and questionnaires
All blood samples were collected after an overnight fast
(> 8-h fasting) and analyzed within 24 h. Plasma glucose
and creatinine levels were measured by performing a
colorimetry immunoassay, and serum triglyceride, HDL
cholesterol, and total cholesterol levels were also mea-
sured using an enzymatic method using an ADVIA 1800
Auto Analyzer (Siemens Medical Solutions, Malvern,
PA, USA). Serum insulin level was measured by per-
forming a chemiluminescence immunoassay using an
ADVIA Centaur XP (Siemens Medical Solutions, Mal-
vern, PA, USA). Serum 25(OH)D level was measured by
using a chemiluminescence immunoassay (Liaison; Dia-
Sorin, Dietzenbach, Germany). Intra- and interassay co-
efficients of variation ranged from 2.9 to 5.5% and from
6.5 to 12.9%, respectively. Estimated glomerular filtration
rate (eGFR) was calculated using the CKD-EPI [15].
Parathyroid hormone (PTH) level was measured by
using an electrochemiluminescence immunoassay
(E-170 modular, Roche, USA). Total coefficients of vari-
ation ranged from 2.8 to 3.4%. Homeostatic model
assessment-insulin resistance (HOMA-IR) was calcu-
lated by using the following equation: [fasting plasma in-
sulin (μIU/mL) × fasting plasma glucose (mg/dL)/405]
[16]. At the first visit, self-reported questionnaires on
patient medical histories, smoking status (current
smoker or not), alcohol drinking status (current drinker
or not), and exercise (currently involved in exercise or
not) were administered.
Statistical analysis
All analyses were stratified by sex. Data were pre-
sented as mean ± standard deviation or median [25th
quartile – 75th quartile], or numbers (n) and percent-
ages (%). Analysis of variance (ANOVA) and
Kruskal-Wallis tests were performed to compare
groups on the basis of quartile of serum 25(OH)D
level. Categorical variables were analyzed by using the
χ2 or Mantel-Haenszel χ2 test. Trend test was per-
formed for MetS and its components on the basis of
the quartile of serum 25(OH)D. Univariate regression
analysis was used to evaluate the associations of
serum 25(OH)D levels with MetS and its components
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including high waist circumference, hypertension,
hyperglycemia, hypertriglyceridemia, and low HDL
cholesterol, respectively. Multivariate logistic regres-
sion analyses were conducted to estimate the associa-
tions between vitamin D status and MetS, as well as
between vitamin D status and each component of
MetS. Model 1 was adjusted by age. Model 2 was ad-
justed by age, exercise status, and smoking status.
Model 3 was adjusted by age, exercise status, smoking
status, region of residence, and seasonality. Model 4
was adjusted by PTH level in addition to the covari-
ates adjusted for in model 3. All statistical analyses
were performed using SAS software, version 9.4 (SAS
Institute Inc., Cary, NC, USA). A p-value of < 0.05
was considered to be statistically significant.
Results
Baseline characteristics
The mean age of 2936 people in total was 71.9 ± 4.6
years (72.8 ± 4.6 years in men and 71.5 ± 4.6 years in
women, respectively). Overall, the mean 25(OH)D
level was 18.0 ± 7.8 ng/mL. The level of serum
25(OH)D was higher in men than those in women
(19.7 ± 7.5 ng/mL in men and 17.1 ± 7.9 ng/mL in
women, p < 0.0001). To evaluate the relationship be-
tween vitamin D levels and MetS, the study popula-
tion was stratified according to the quartiles of
serum 25(OH)D level for each sex. Clinical and bio-
chemical characteristics of the participants divided
into 4 groups stratified by sex are shown in Tables 1
and 2, respectively. For both sexes, waist circumfer-
ence, PTH level, insulin level, and HOMA-IR, total
cholesterol level, and triglyceride level were higher
in the lowest 25(OH)D quartile, compared with the
highest quartile of 25(OH)D. There were no differ-
ences in age, body mass index, systolic and diastolic
blood pressure, eGFR, and HDL cholesterol level
among the 4 groups. The life style parameters such
as smoking and drinking did not significantly differ
among the 4 groups for both sexes. The number of
MetS components was highest in the lowest
25(OH)D quartile and lowest in the highest
25(OH)D quartile in both sexes.
Association of serum 25(OH)D levels with MetS and its
components
Among all participants, 45.4% of participants had MetS.
The prevalence of MetS was higher in women (50.0%)
than in men (36.4%). The prevalence of MetS according
to quartile of vitamin D was presented in Fig. 1. As the
25(OH)D level decreased, the prevalence of MetS in-
creased in both sexes (p for trend < 0.001, both sexes)
(Fig. 1). The prevalence of high waist circumference,
hypertriglyceridemia, and low HDL cholesterol
Table 1 Baseline characteristics of men according to serum 25(OH)D level
Quartile (n)
(ng/mL)
Quartile 1 (n = 245)
(4.20–14.19)
Quartile 2 (n = 245)
(14.20–18.99)
Quartile 3 (n = 249)
(19.00–24.19)
Quartile 4 (n = 248)
(24.20–51.90)
P value
25(OH)D, ng/mL 10.90 ± 2.28 16.53 ± 1.39 21.41 ± 1.50 29.67 ± 5.34 < 0.001
Age, yr 73.01 ± 4.87 72.38 ± 4.14 72.59 ± 4.47 73.27 ± 4.87 0.132
BMI, kg/m2 23.99 ± 2.63 24.19 ± 2.61 23.65 ± 2.67 23.60 ± 2.90† 0.053
Waist, cm 87.49 ± 8.13 86.68 ± 8.44 86.43 ± 8.78 83.48 ± 9.33*†‡ < 0.001
SBP, mmHg 125.89 ± 14.50 128.51 ± 14.24 129.70 ± 14.41 128.86 ± 13.88 0.370
DBP, mmHg 74.10 ± 8.91 73.68 ± 9.28 75.23 ± 8.35 73.02 ± 7.90 0.420
Current smoking 42 (17.1) 53 (21.6) 36 (14.5) 53 (21.4) 0.117
Current drinking 205 (66.6) 194 (64.2) 138 (58) 72 (51.8) 0.011
Exercise 151 (61.4) 164 (66.9) 164 (65.9) 132 (53.2) 0.007
eGFR 77.5 ± 15.11 79.8 ± 14.03 81.06 ± 13.19* 80.13 ± 13.44 0.036
PTH 39.68 ± 14.13 38.07 ± 17.25 35.80 ± 12.07 33.83 ± 11.62*† < 0.001
Glucose, mg/dL 101.59 ± 23.61 100.47 ± 20.17 99.91 ± 19.90 97.50 ± 19.93 0.171
Insulin, IU/L 7.53 ± 8.31 7.57 ± 12.22 6.12 ± 4.26 5.18 ± 3.26*† 0.001
HOMA-IR 1.93 ± 2.24 1.86 ± 2.42 1.55 ± 1.24 1.29 ± 0.99*† < 0.001
Total cholesterol, mg/dL 174.51 ± 32.91 172.92 ± 33.72 173.93 ± 33.09 163.70 ± 29.95*†‡ < 0.001
Triglyceride, mg/dL 138.69 ± 78.55 128.43 ± 71.30 125.45 ± 61.22 110.31 ± 46.04*† < 0.001
HDL cholesterol, mg/dL 45.99 ± 12.13 47.89 ± 12.56 46.98 ± 10.45 48.15 ± 11.26 0.157
Number of MetS components 2.22 ± 1.30 2.16 ± 1.23 2.02 ± 1.25 1.73 ± 1.18*† < 0.001
Data were shown as mean ± SD or number (%). 25(OH)D, vitamin D3, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR
estimated glomerular filtration rate, HOMA-IR homeostatic model assessment - insulin resistance, HDL high density lipoprotein, MetS metabolic syndrome. * vs. Q1,
† vs. Q2, ‡ vs. Q3
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significantly increased with decreasing vitamin D level;
however, the prevalence of hyperglycemia showed this
trend only in men (p for trend = 0.011) (Table 3). Hyper-
tension did not show a significant change with decreas-
ing level of vitamin D in both sexes. On univariate
analysis (Table 3), the odds of MetS significantly in-
creased in the lowest quartile of 25(OH)D level (OR 2.22
[95% CI, 1.52–2.34] in men and 1.98 [95% CI, 1.60–2.44]
in women). To control potential confounding factors
that affect the outcome in addition to age; smoking, al-
cohol, and exercise statuses; seasonality, which could
affect serum 25(OH)D level depending on the time when
the examination was performed; and region of residence
in which the participants live (e.g., rural or urban), were
further adjusted in model 3 (Tables 4 and 5). The odds
of MetS, high waist circumference, hypertriglyceridemia,
and low HDL in the lower quartile groups were higher
compared to those in the highest quartile group of
25(OH)D level in both men and women. With further
adjustment for PTH in model 4, the pattern was similar;
however, the association of high waist circumference in
lowest quartile of serum 25(OH)D level disappeared in
women (OR 1.28 [95% CI, 0.97–1.68]), however, was
persisted in men (OR 1.81 [95% CI, 1.19–2.77.
Table 2 Baseline characteristics of women according to serum 25(OH)D level
Quartile (n)
(ng/mL)
Quartile 1 (n = 487)
(4.10–11.19)
Quartile 2 (n = 491)
(11.20–15.59)
Quartile 3 (n = 484)
(15.60–21.59)
Quartile 4 (n = 487)
(21.60–54.90)
P value
25(OH)D, ng/mL 8.72 ± 1.67 13.28 ± 1.28 18.31 ± 1.70 28.15 ± 5.56 < 0.001
Age, yr 72.16 ± 4.68 71.07 ± 4.71 71.27 ± 4.35 71.45 ± 4.54*†‡ 0.001
BMI, kg/m2 24.69 ± 2.92 25.07 ± 3.31 24.74 ± 3.11 23.58 ± 2.85*†‡ < 0.001
Waist, cm 83.49 ± 8.71 83.63 ± 9.13 83.14 ± 8.52 81.07 ± 8.54*†‡ < 0.001
SBP, mmHg 129.69 ± 15.75 128.51 ± 16.42 125.83 ± 15.46 124.69 ± 15.21* 0.026
DBP, mmHg 74.15 ± 7.96 73.32 ± 8.65 72.55 ± 8.75 72.96 ± 9.28 0.451
Current smoking 7 (1.4) 12 (2.4) 5 (1) 5 (1) 0.216
Current drinking 99 (23.2) 91 (20.6) 145 (28.4) 137 (24) 0.043
Exercise 293 (60.2) 308 (62.7) 294 (60.7) 294 (60.4) 0.855
eGFR 81.04 ± 15.49 82.51 ± 13.94 82.74 ± 13.23 83.68 ± 11.50* 0.024
PTH 46.36 ± 19.35 41.12 ± 14.40 37.70 ± 14.11 36.28 ± 13.80*† < 0.001
Glucose, mg/dL 96.11 ± 16.34 99.40 ± 20.33 98.17 ± 19.57 95.76 ± 15.56† 0.004
Insulin, IU/L 7.63 ± 4.79 8.09 ± 5.69 7.60 ± 5.07 6.85 ± 7.55† 0.011
HOMA-IR 1.85 ± 1.35 2.07 ± 1.67 1.89 ± 1.47 1.68 ± 2.23† 0.005
Total cholesterol, mg/dL 190.70 ± 38.79 185.70 ± 32.22 187.60 ± 36.56 180.07 ±34.45*‡ < 0.001
Triglyceride, mg/dL 143.47 ± 72.92 127.91 ± 61.37 128.05 ± 57.94 115.83 ± 51.41*†‡ < 0.001
HDL cholesterol, mg/dL 49.85 ± 12.58 51.63 ± 12.61 52.29 ± 12.13 52.30 ± 12.12* 0.005
Number of MetS components 2.65 ± 1.29 2.52 ± 1.30 2.50 ± 1.32 2.26 ± 1.31*†‡ < 0.001
Data were shown as mean ± SD or number (%). 25(OH)D, vitamin D3, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR
estimated glomerular filtration rate, HOMA-IR homeostatic model assessment - insulin resistance, HDL high density lipoprotein, MetS metabolic syndrome. * vs. Q1,
† vs. Q2, ‡ vs. Q3
Fig. 1 The prevalence of metabolic syndrome and its components, on the basis of serum 25(OH)D level
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Discussion
The relationship between vitamin D levels and MetS has
been widely studied in several populations [8, 11, 17,
18]. However, most studies have not exclusively exam-
ined this association in elderly participants. With aging,
cutaneous vitamin D production is reduced [4]. With
aging, there are reductions in the renal production of
1,25(OH)2D by the kidneys, calcium absorption, and the
action of vitamin D receptors [19]. Moreover, MetS is a
concern throughout the aged society [20], as it is related
to insulin resistance and obesity. Further, Vitamin D is
lipid-soluble and is sequestered in fat tissue, which leads
to lower vitamin D levels in obesity [21]. Thus, a specific
relationship is expected between vitamin D levels and
MetS prevalence in the elderly.
In this community-based cohort study involving Korean
men and women aged ≥65 years, we demonstrated that
the risk of MetS was significantly higher in the lowest
quartile compared to the highest quartile of the vitamin D
level in both men and women. In particular, we found that
a lower vitamin D level is significantly associated with a
higher prevalence of high waist circumference, elevated
triglyceride level, and low HDL level in both sexes inde-
pendent of age, smoking status, alcohol drinking status,
exercise status, region of residence, and seasonality.
Vitezova et al. revealed that higher 25(OH)D concen-
trations in the elderly were associated with lower preva-
lence of MetS and with higher HDL-cholesterol, lower
triglyceride, lower waist circumference, and lower serum
glucose [11]. However, in that study the results were
combined for both men and women, and included both
middle-aged and elderly adults; in contrast, in the
present study, the results were stratified by sex, and the
age of the study participants was ≥65 years. Vitezova et
al. [11] also reported a significant effect modification by
sex (P interactions < 0.05) in a subgroup analysis. They
showed that a lower prevalence of high triglyceride level
was significantly associated with high vitamin D level,
similar to our findings.
In our study, MetS and its components, including
hypertriglyceridemia and low-HDL level, were associ-
ated with vitamin D level in the lowest quartile
group in both men and women in all models. How-
ever, the significance of the association between high
waist circumference and vitamin D level in the low-
est quartile group was maintained in men, but not
in women. After additional adjustment by PTH level,
the association between high waist circumference
and vitamin D level was not maintained in men.
Vitamin D deficiency causes elevation of PTH, which
also affects the storage of fat [22]. Waist circumfer-
ence is measured to reflect abdominal obesity; how-
ever, it does not completely represent the amount of
visceral fat, which is more related to insulin resist-
ance, and fat distribution, which could differ accord-
ing to sex. Kim et al. [23] suggested sex-specific
association of PTH and vitamin D with MetS. How-
ever, we did not observe a sex-specific effect on the
association between vitamin D level and MetS, or
between vitamin D level and specific MetS compo-
nents. Bea et al. observed significant inverse relation-
ships between 1,25(OH)2D and high triglyceride
level; however, for 25(OH)D concentrations, signifi-
cant inverse relationships were observed with MetS,
waist circumference, and triglyceride [24]. In our
sensitivity analysis for total population, 25(OH)D
level as a continuous variable showed significant in-
verse relationships with MetS (OR 0.97, 95% confi-
dence interval 0.96–0.98) by adjusting age, sex,
smoking, alcohol, exercise, region of residence, sea-
sonality, PTH. Oosterwerff et al. showed an in-
creased risk of MetS in participants who were > 65
Table 3 Association of serum 25(OH)D levels with metabolic syndrome and its components in men and women
25(OH)D Metabolic syndrome Abdominal obesity Hypertension Hyperglycemia Hypertriglyceridemia low HDL
Men Univariate OR
Quartile 1 2.22 (1.52–3.24) 2.03 (1.39–2.99) 0.96 (0.65–1.43) 1.48 (1.03–2.13) 2.13 (1.40–3.24) 1.77 (1.18–2.63)
Quartile 2 1.85 (1.26–2.70) 1.93 (1.32–2.84) 1.05 (0.70–1.56) 1.72 (1.20–2.47) 1.78 (1.16–2.74) 1.35 (0.90–2.03)
Quartile 3 1.57 (1.07–2.30) 1.73 (1.17–2.54) 1.05 (0.71–1.56) 1.26 (0.88–1.82) 1.78 (1.16–2.73) 1.07 (0.70–1.62)
Quartile 4 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
P for trend < 0.001 < 0.001 0.860 0.011 0.001 0.002
Women Univariate OR
Quartile 1 1.98 (1.60–2.44) 1.42 (1.09–1.84) 1.30 (0.98–1.72) 1.11 (0.85–1.45) 2.13 (1.60–2.83) 1.37 (1.06–1.76)
Quartile 2 1.40 (1.09–1.81) 1.35 (1.04–1.74) 1.20(0.91–1.58) 1.30 (1.00–1.69) 1.43 (1.07–1.92) 1.12 (0.87–1.44)
Quartile 3 1.43 (1.11–1.85) 1.43 (1.10–1.85) 1.21 (0.92–1.60) 1.17 (0.90–1.53) 1.43 (1.06–1.92) 1.05 (0.81–1.35)
Quartile 4 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
P for trend < 0.001 0.017 0.082 0.343 0.001 0.013
25(OH)D: 25-OH-vitamin D, OR odds ratio, CI confidence interval, HDL high-density lipoprotein
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years of age with vitamin D level < 50 nmol in the
Netherlands [25]. They showed that low HDL chol-
esterol levels and high waist circumference were re-
lated to vitamin D deficiency. In that study, both
sexes were analyzed together. When we analyzed
both sexes together, the risk of MetS and its compo-
nents including high waist circumference, hypertriglyc-
eridemia and low HDL were significantly higher in the
lowest quartile compared to the highest quartile of the vita-
min D level. An additional file 1 shows this in more detail
(see Additional file 1). Compared with the other studies, a
possible explanation for the distinct findings of our results
may comprise differences in the ages of participants in the
studies. The differences in results regarding the associations
between vitamin D level and MetS components in young
and middle-aged populations stratified on the basis of sex
may be influenced by hormonal levels [10, 26]. In our study,
no significant associations were observed between vitamin
D levels and hypertension or hyperglycemia, which may
have occurred because the participants included individuals
already taking antihypertensive or antidiabetic drugs.
This study has certain limitations. First, this was a
cross-sectional study. A meta-analysis has shown that while
the correlation between serum vitamin D status and MetS
Table 4 Multivariable-adjusted odds ratio of metabolic syndrome and its components according to serum 25(OH)D levels in men
Men Vitamin D level
1st quartile 2nd quartile 3rd quartile 4th quartile
OR CI OR CI OR CI
Metabolic syndrome
Model 1 2.22 (1.52 – 3.24) 1.84 (1.26 – 2.70) 1.56 (1.06 – 2.30) 1 (Reference)
Model 2 2.27 (1.55 – 3.33) 1.87 (1.27 – 2.75) 1.55 (1.05 – 2.28)
Model 3 2.03 (1.34 – 3.07) 1.70 (1.14 – 2.55) 1.45 (0.98 – 2.16)
Model 4 2.25 (1.48 – 3.43) 1.83 (1.22 – 2.74) 1.51 (1.02 – 2.24)
Abdominal obesity
Model 1 2.03 (1.38 – 2.98) 1.92 (1.31 – 2.83) 1.72 (1.17 – 2.53) 1
Model 2 2.10 (1.43 –3.10) 1.99 (1.35 – 2.93) 1.73 (1.17 – 2.56)
Model 3 1.81 (1.19 – 2.75) 1.79 (1.19 – 2.68) 1.64 (1.10 – 2.44)
Model 4 1.81 (1.19 – 2.77) 1.79 (1.19 – 2.69) 1.64 (1.10 – 2.45)
Hypertension
Model 1 0.97 (0.65 – 1.44) 1.07 (0.72 – 1.60) 1.07 (0.72 – 1.59) 1
Model 2 1.03 (0.69 – 1.55) 1.10 (0.73 – 1.65) 1.05 (0.70 – 1.57)
Model 3 1.05 (0.68 – 1.62) 1.10 (0.72 – 1.69) 1.04 (0.69 – 1.57)
Model 4 1.07 (0.69 – 1.67) 1.12 (0.73 – 1.72) 1.05 (0.69 – 1.59)
Hyperglycemia
Model 1 1.48 (1.03 – 2.13) 1.72 (1.20 – 2.47) 1.26 (0.88 – 1.82) 1
Model 2 1.49 (1.03 – 2.14) 1.69 (1.17 – 2.44) 1.22 (0.85 – 1.76)
Model 3 1.18 (0.79 – 1.75) 1.42 (0.97 – 2.09) 1.10 (0.75 – 1.60)
Model 4 1.34 (0.90 – 2.01) 1.57 (1.06 – 2.31) 1.15 (0.79 – 1.68)
Hypertriglycemia
Model 1 2.11 (1.38 – 3.23) 1.74 (1.13 – 2.67) 1.74 (1.14 – 2.68) 1
Model 2 2.27 (1.47 – 3.48) 1.79 (1.16 – 2.76) 1.83 (1.19 – 2.82)
Model 3 2.41 (1.51 – 3.86) 1.87 (1.19 – 2.96) 1.89 (1.21 – 2.94)
Model 4 2.77 (1.72 – 4.48) 2.05 (1.29 – 3.25) 1.99 (1.28 – 3.11)
Low HDL
Model 1 1.76 (1.18 – 2.63) 1.34 (0.89 – 2.02) 1.06 (0.70 – 1.62) 1
Model 2 1.61 (1.07 – 2.41) 1.30 (0.86 – 1.97) 1.04 (0.68 – 1.59)
Model 3 1.55 (1.00 – 2.41) 1.28 (0.83 – 1.98) 1.04 (0.67 – 1.61)
Model 4 1.70 (1.09 – 2.67) 1.36 (0.88 – 2.12) 1.07 (0.69 – 1.66)
Model 1: age adjusted, Model 2: Model 1 + smoking, alcohol, exercise adjusted, Model 3: Model 2 + region, seasonality adjusted, Model 4: Model 3 + parathyroid
hormone adjusted, OR odds ratio, CI confidence interval, HDL high density lipoprotein
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prevalence in the general adult population has been
established in cross-sectional studies, a significant
relationship has not been reproduced in longitudinal
studies [8]. However, in that meta-analysis the study
populations of the included studies were
heterogenous. The present cohort is scheduled to be
followed-up. Thus, the longitudinal data obtained
will be analyzed to explore the association between
the change in vitamin D status and incidence of
MetS in this population. Second, we could not con-
sider factors such as calcium and vitamin D intake,
which could have affected the serum levels of vita-
min D. Nonetheless, the present study also has im-
portant strengths. Most previous studies included
adults with age > 20 years or women in their 50s
during the early-postmenopausal period. However,
our study exclusively focused on the elderly Korean
participants aged ≥65 years and our analyses were
also stratified by sex. Thus, the effects of the vitamin
D level were examined with little or no hormonal
effect.
Conclusions
In conclusion, vitamin D deficiency is associated with a
higher prevalence of MetS in Korean elderly men and
women. Adequate vitamin D level is important to de-
crease the risk of MetS. Further studies should evaluate
the effect of vitamin D supplements on MetS prevalence
in the elderly.
Table 5 Multivariable-adjusted odds ratio of metabolic syndrome and its components according to serum 25(OH)D levels in women
Women Vitamin D level
1st quartile 2nd quartile 3rd quartile 4th quartile
OR CI OR CI OR CI
Metabolic syndrome
Model 1 1.63 (1.27 – 2.11) 1.43 (1.11 – 1.84) 1.45 (1.12 – 1.86) 1 (reference)
Model 2 1.35 (1.27 – 2.12) 1.45 (1.12 – 1.86) 1.45 (1.12 – 1.87)
Model 3 1.61 (1.24 – 2.09) 1.42 (1.10 – 1.84) 1.43 (1.11 – 1.84)
Model 4 1.65 (1.27 – 2.16) 1.44 (1.12 – 1.87) 1.43 (1.11 – 1.85)
Abdominal obesity
Model 1 1.39 (1.07 – 1.81) 1.36 (1.05 – 1.76) 1.44 (1.11 – 1.86) 1
Model 2 1.39 (1.08 – 1.81) 1.36 (1.05 – 1.77) 1.44 (1.11 – 1.87)
Model 3 1.33 (1.02 – 1.74) 1.33 (1.03 – 1.73) 1.42 (1.09 – 1.84)
Model 4 1.28 (0.97 – 1.68) 1.30 (1.00 – 1.70) 1.41 (1.08 – 1.83)
Hypertension
Model 1 1.24 (0.94 – 1.65) 1.24 (0.94 – 1.64) 1.23 (0.93 – 1.63) 1
Model 2 1.24 (0.94 – 1.65) 1.24 (0.94 – 1.64) 1.23 (0.93 – 1.63)
Model 3 1.30 (0.97 – 1.73) 1.27 (0.96 – 1.68) 1.25 (0.94 – 1.66)
Model 4 1.24 (0.92 – 1.66) 1.24 (0.93 – 1.64) 1.24 (0.93 – 1.64)
Hyperglycemia
Model 1 1.09 (0.83 – 1.42) 1.31 (1.01 – 1.71) 1.18 (0.90 – 1.54) 1
Model 2 1.08 (0.83 – 1.42) 1.31 (1.00 – 1.70) 1.18 (0.90 – 1.54)
Model 3 1.05 (0.80 – 1.38) 1.28 (0.98 – 1.67) 1.15 (0.88 – 1.51)
Model 4 1.14 (0.86 – 1.51) 1.33 (1.02 – 1.75) 1.17 (0.89 – 1.53)
Hypertriglycemia
Model 1 2.14 (1.61 – 2.85) 1.42 (1.06 – 1.91) 1.43 (1.06 – 1.91) 1
Model 2 2.16 (1.62 – 2.88) 1.44 (1.07 – 1.44) 1.43 (1.06 – 1.92)
Model 3 2.12 (1.59 – 2.84) 1.44 (1.07 – 1.93) 1.43 (1.06 – 1.93)
Model 4 2.14 (1.59 – 2.89) 1.44 (1.07 – 1.95) 1.43 (1.07 – 1.93)
Low HDL
Model 1 1.35 (1.05 – 1.73) 1.13 (0.88 – 1.46) 1.05 (0.82 – 1.35) 1
Model 2 1.36 (1.05 – 1.75) 1.15 (0.90 – 1.49) 1.05 (0.82 – 1.35)
Model 3 1.38 (1.07 – 1.79) 1.17 (0.90 – 1.50) 1.06 (0.82 – 1.37)
Model 4 1.39 (1.07 – 1.81) 1.17 (0.91 – 1.51) 1.06 (0.82 – 1.37)
Model 1: age adjusted, Model 2: Model 1 + smoking, alcohol, exercise adjusted, Model 3: Model 2 + region, seasonality adjusted, Model 4: Model 3 + parathyroid
hormone adjusted, OR odds ratio, CI confidence interval, HDL high density lipoprotein
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